Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Nature Biotechnology
|
November 27, 2023
Tracing the fate of AAV vectors in the body
Nerea Zabaleta, Irene Gil-Farina
Human Gene Therapy
|
July 27, 2019
Genetic-Based Approaches to Inherited Metabolic Liver Diseases
Nerea Zabaleta, Mirja Hommel, David Salas, et al.
Nature Reviews. Gastroenterology & Hepatology
|
January 16, 2023
Gene therapy for liver diseases - progress and challenges
Nerea Zabaleta, Carmen Unzu, Nicholas D Weber, et al.
Hepatology (Baltimore, Md.)
|
March 4, 2022
mRNA and gene editing: Late breaking therapies in liver diseases
Nerea Zabaleta, Laura Torella, Nicholas D Weber, et al.
FEBS Letters
|
July 30, 2024
Gene editing in liver diseases
Laura Torella, Nerea Santana-Gonzalez, Nerea Zabaleta, et al.
Molecular Therapy. Methods & Clinical Development
|
December 13, 2024
E2A, VA RNA I, and L4-22k adenoviral helper genes are sufficient for AAV production in HEK293 cells
Jiten Doshi, Emma Couto, Jillian Staiti, et al.
JHEP Reports : Innovation in Hepatology
|
June 23, 2021
Novel vectors and approaches for gene therapy in liver diseases
Sheila Maestro, Nicholas D Weber, Nerea Zabaleta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 10, 2017
Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5<sup>ch</sup> and AAV1
Anna Majowicz, David Salas, Nerea Zabaleta, et al.
Viruses
|
April 23, 2022
Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging
Dawid Maciorowski, Cheikh Diop, Urja Bhatt, et al.
Blood Advances
|
September 11, 2019
Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates
David Salas, Karin L Kwikkers, Nerea Zabaleta, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Nature Biotechnology
|
November 27, 2023
Tracing the fate of AAV vectors in the body
Nerea Zabaleta, Irene Gil-Farina
Human Gene Therapy
|
July 27, 2019
Genetic-Based Approaches to Inherited Metabolic Liver Diseases
Nerea Zabaleta, Mirja Hommel, David Salas, et al.
Nature Reviews. Gastroenterology & Hepatology
|
January 16, 2023
Gene therapy for liver diseases - progress and challenges
Nerea Zabaleta, Carmen Unzu, Nicholas D Weber, et al.
Hepatology (Baltimore, Md.)
|
March 4, 2022
mRNA and gene editing: Late breaking therapies in liver diseases
Nerea Zabaleta, Laura Torella, Nicholas D Weber, et al.
FEBS Letters
|
July 30, 2024
Gene editing in liver diseases
Laura Torella, Nerea Santana-Gonzalez, Nerea Zabaleta, et al.
Molecular Therapy. Methods & Clinical Development
|
December 13, 2024
E2A, VA RNA I, and L4-22k adenoviral helper genes are sufficient for AAV production in HEK293 cells
Jiten Doshi, Emma Couto, Jillian Staiti, et al.
JHEP Reports : Innovation in Hepatology
|
June 23, 2021
Novel vectors and approaches for gene therapy in liver diseases
Sheila Maestro, Nicholas D Weber, Nerea Zabaleta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 10, 2017
Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5<sup>ch</sup> and AAV1
Anna Majowicz, David Salas, Nerea Zabaleta, et al.
Viruses
|
April 23, 2022
Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging
Dawid Maciorowski, Cheikh Diop, Urja Bhatt, et al.
Blood Advances
|
September 11, 2019
Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates
David Salas, Karin L Kwikkers, Nerea Zabaleta, et al.
Page
of 3